A native of the American south (USA), Rebecca graduated from medicine school in 1998 and subsequently trained in both internal medicine and infectious diseases. She worked in both inpatient and outpatient health care settings for a number of years, taking care of patients with both general medical problems as well as infectious diseases.
She moved to Uppsala in 2008 to work at the Swedish Medical Products Agency in the department of drug safety. Her primary responsibility at the MPA was the assessment of periodic safety reports, risk management plans and signal evaluations for currently marketed medical products licensed in the EU, including the pneumococcal and HPV vaccines in current widespread use today. She fell in love with pharmacovigilance almost immediately upon arrival; however, it was the Pandemrix – narcolepsy experience which resulted in a specific interest in vaccine safety. During her time at the MPA, she completed both the Certificate course in Pharmacoepidemiology and Pharmacovigilance and the short course in Practical Pharmacoepidemiology at the London School of Hygiene and Tropical Medicine.
She was thrilled to accept an invitation to work at the Uppsala Monitoring Centre in 2014 where she now works in the Research section, providing medical expertise in signal detection and analysis and in research projects to evaluate novel methods to analyse observational medical data. She also contributes and participates in training courses and scientific courses in Sweden and abroad.